✦ LIBER ✦

Human trials go-ahead for the AIDS vaccine with a difference

✍ Scribed by Newmark, Peter

Book ID: 109753783
Publisher: Nature Publishing Group
Year: 1988
Tongue: English
Weight: 130 KB
Volume: 332
Category: Article
ISSN: 0028-0836
DOI: 10.1038/332770a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1/2 trial of BMS-275291 in patient

Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma : A multicenter trial of the AIDS Malignancy Consortium

✍ Brett T. Brinker; Susan E. Krown; Jeannette Y. Lee; Ethel Cesarman; Amy Chadburn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## BACKGROUND. Matrix metalloproteinases (MMPs) are overexpressed in Kaposi sarcoma (KS). The safety and efficacy of a novel, orally bioavailable MMP inhibitor, BMS‐275291, was evaluated in patients with human immunodeficiency virus‐associated KS and the correlation between changes in

Adenocarcinoma in situ and associated hu

Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

✍ Kevin A. Ault; Elmar A. Joura; Susanne K. Kjaer; Ole-Erik Iversen; Cosette M. Wh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB

## Abstract The primary objective of this report is to describe the detection of adenocarcinoma __in situ__ (AIS) and associated human papillomavirus (HPV) type distribution that was observed in the context of two phase 3 clinical trials of a quadrivalent HPV6/11/16/18 vaccine. In this intention‐to

Studies of the vaccine virus isolated du

Studies of the vaccine virus isolated during a trial with an attenuated poliovirus vaccine prepared in a human diploid cell strain, including use of a strain-specific bovine serum inhibitor

✍ Joseph S. Pagano; Margareta Böttiger 📂 Article 📅 1964 🏛 Springer Vienna 🌐 English ⚖ 931 KB

Phase I clinical study of a peptide vacc

Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles

✍ Shigeru Yutani; Nobukazu Komatsu; Shigeki Shichijo; Kazumi Yoshida; Hiroko Taked 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 840 KB

Strong immunogenicity of a multicomponen

Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection

✍ Kenji Okuda; Tamiko Kaneko; Tadashi Yamakawa; Shunichi Tanaka; Takashi Shigemats 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 900 KB

## Abstract We synthesized one V3 peptide each from HTLV‐III~B~, Thai A and Thai B, conjugating then to the T cell epitope of the __env__ region, and we also synthesized a p17 protein peptide of the __gag__ region (HGP‐30). These peptide were then coupled to 8‐lysine copolymers using __N__‐succinim

The clinical effectiveness of different

The clinical effectiveness of different parenting programmes for children with conduct problems: a systematic review of randomised controlled trials

✍ Richard Reading 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB